Use of the Low-Molecular-Weight Heparin Reviparin to Prevent Deep-Vein Thrombosis after Leg Injury Requiring Immobilization
Open Access
- 5 September 2002
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 347 (10) , 726-730
- https://doi.org/10.1056/nejmoa011327
Abstract
Deep-vein thrombosis is a well-recognized complication after trauma to the legs and subsequent immobilization, but there are no generally accepted approaches to preventing this complication.Keywords
This publication has 21 references indexed in Scilit:
- PHARMACOLOGY OF LOW MOLECULAR WEIGHT HARPARINSEmergency Medicine Clinics of North America, 2001
- Efficacy and Safety of Prolonged Thromboprophylaxis with a Low Molecular Weight Heparin (Dalteparin) after Total Hip Arthroplasty— The Danish Prolonged Prophylaxis (DaPP) StudyThrombosis Research, 1998
- Total Achilles Tendon RuptureSports Medicine, 1998
- Low-Molecular-Weight Heparin (Enoxaparin) as Prophylaxis against Venous Thromboembolism after Total Hip ReplacementNew England Journal of Medicine, 1996
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- A Prospective Study of Venous Thromboembolism after Major TraumaNew England Journal of Medicine, 1994
- Real-time B-mode ultrasonography in the diagnosis of postoperative deep vein thrombosis in non-symptomatic high-risk patientsEuropean Journal of Vascular Surgery, 1990
- Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED InvestigatorsJAMA, 1990
- Calf deep venous thrombosis. A wolf in sheep's clothing?Archives of internal medicine (1960), 1988
- THE INJURY SEVERITY SCOREPublished by Wolters Kluwer Health ,1974